1538 related articles for article (PubMed ID: 26703800)
1. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
2. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
3. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles in lung cancer-From bench to bedside.
Kadota T; Yoshioka Y; Fujita Y; Kuwano K; Ochiya T
Semin Cell Dev Biol; 2017 Jul; 67():39-47. PubMed ID: 28267596
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of tumor microenvironment derived exosomes in therapeutic resistance and metastasis through epithelial-to-mesenchymal transition.
Balaji S; Kim U; Muthukkaruppan V; Vanniarajan A
Life Sci; 2021 Sep; 280():119750. PubMed ID: 34171378
[TBL] [Abstract][Full Text] [Related]
6. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation.
Fantozzi A; Gruber DC; Pisarsky L; Heck C; Kunita A; Yilmaz M; Meyer-Schaller N; Cornille K; Hopfer U; Bentires-Alj M; Christofori G
Cancer Res; 2014 Mar; 74(5):1566-75. PubMed ID: 24413534
[TBL] [Abstract][Full Text] [Related]
7. Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.
El-Nikhely N; Larzabal L; Seeger W; Calvo A; Savai R
Expert Opin Investig Drugs; 2012 Aug; 21(8):1107-22. PubMed ID: 22667993
[TBL] [Abstract][Full Text] [Related]
8. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
9. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells.
Russi S; Verma HK; Laurino S; Mazzone P; Storto G; Nardelli A; Zoppoli P; Calice G; La Rocca F; Sgambato A; Lucci V; Falco G; Ruggieri V
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370155
[TBL] [Abstract][Full Text] [Related]
10. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
11. Toward Normalization of the Tumor Microenvironment for Cancer Therapy.
Zheng J; Gao P
Integr Cancer Ther; 2019; 18():1534735419862352. PubMed ID: 31282197
[TBL] [Abstract][Full Text] [Related]
12. The hypoxic tumor microenvironment: driving the tumorigenesis of non-small-cell lung cancer.
Foster JG; Wong SC; Sharp TV
Future Oncol; 2014 Dec; 10(16):2659-74. PubMed ID: 25531051
[TBL] [Abstract][Full Text] [Related]
13. Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets.
Szebeni GJ; Vizler C; Nagy LI; Kitajka K; Puskas LG
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886105
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells in lung cancer tumor microenvironment: their biological properties, influence on tumor growth and therapeutic implications.
Liu R; Wei S; Chen J; Xu S
Cancer Lett; 2014 Oct; 353(2):145-52. PubMed ID: 25128070
[TBL] [Abstract][Full Text] [Related]
15. Insights into the role of components of the tumor microenvironment in oral carcinoma call for new therapeutic approaches.
Salo T; Vered M; Bello IO; Nyberg P; Bitu CC; Zlotogorski Hurvitz A; Dayan D
Exp Cell Res; 2014 Jul; 325(2):58-64. PubMed ID: 24462456
[TBL] [Abstract][Full Text] [Related]
16. Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer.
Anari F; Ramamurthy C; Zibelman M
Future Oncol; 2018 Jun; 14(14):1409-1421. PubMed ID: 29848096
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
Roy Burman D; Das S; Das C; Bhattacharya R
Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
[TBL] [Abstract][Full Text] [Related]
18. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
Du B; Shim JS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation in the tumor microenvironment.
Zhang MW; Fujiwara K; Che X; Zheng S; Zheng L
J Zhejiang Univ Sci B; 2017 May; 18(5):365-372. PubMed ID: 28471108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
